This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Patent and Trademark Office (USPTO) today released an official Artificial Intelligence Strategy aimed at outlining the challenges faced by the Office both internally and externally, as the reach of AI impacts all aspects of innovation and society.
PatentApplication No. 18/140,658, entitled “Interacting with a Language Model using External Knowledge and Feedback,” in April 2023. The application published on October 31, 2024, and became available for public inspection. It filed U.S. By: Robinson+Cole Data Privacy + Security Insider
The looming threat is the pending patentapplications by Gilead in India. A Look at the Pre-Grant Oppositions Gilead has multiple patentapplications for Lenacapavir in India, including those seeking patents on its choline and sodium salts. and the oppositions raised against these applications.
In Plant-e v Bioo the UPC provided its first decision addressing the doctrine of equivalents in patent infringement proceedings ( UPC_CFI_239/2023 ). Case details: Plant-based fuel cells The dispute in UPC_CFI_239/2023 concerned EP2137782 , owned by Plant-e Knowledge B.V.
Image from the Report The US Trade Representative (USTR) released the Special 301 Report for 2023 on April 26, 2023, and has placed India in the ‘Priority Watch List’, yet again. Prabhat Kumar Saha highlighting certain concerns of the USTR in the 2023 Special 301 Report and assessing the same from a public health perspective.
by Dennis Crouch The US Patent and Trademark Office (USPTO) issued a total of 312,100 utility patents in the calendar year 2023. This marks the fourth consecutive year of decline in the number of issued patents. So this data is more of a backwards-looking snapshot.
On April 18, 2023, we submitted a Supreme Court amicus brief expressing our encouragement for the justices to rule on the question of whether it is proper for an artificial intelligence (AI) to be an inventor on a patentapplication. By: McDonnell Boehnen Hulbert & Berghoff LLP
2021-2022 was a big year for the Osgoode’s mooting team entry for the USPTO National PatentApplication Drafting Competition. We invite you to participate in the tryouts for the 2022-2023 National PatentApplication Drafting Competition ! About the National PatentApplication Drafting Competition.
patent system from a first-to-invent system to a first-to-file system. Under a first-to-invent system, the first person to come up with an invention has “priority” and is entitled to a patent even if there was an earlier filed patentapplication from a different inventor covering the same invention.
The updated EPO Guidelines for Examination will enter into force on 1 March 2023. The main updates this year are those taking account of the new sequence listing standard, the imminent arrival of the Unified Patent Court and the new Rule 56a EPC on erroneously filed parts. A draft version of the Guidelines can be previewed here.
Today, the World Intellectual Property Organization (WIPO) published its annual World Intellectual Property Indicators Report, providing a snapshot of IP filing activities across the globe during 2023.
The Controller had rejected a patentapplication by Arcturus Therapeutics for the applicants inability to file its second written submission on time. ” The Patent Office refused the application solely on procedural grounds, citing a delay in filing additional written submissions. In Blackberry Limited v.
As 2023 comes to an end, in line with our annual tradition, we take stock of the top IP developments that occurred this year. We have also included a list of other notable IP developments of 2023. The judgement was passed in October 2022, but was uploaded in September 2023 on the High Court’s website. A special thanks to Mr. G.
In the recent UK case of Philip Morris v BAT [2023] EWHC 2616 (Pat) , His Honour Justice Hacon (Hacon HHJ) considered the standard for invalidity due to added matter. Invalidity in view of added matter is a common patent pitfall in Europe ( IPKat ).
The complaint sought director review of a 2018 Patent Trial & Appeal Board decision that affirmed a rejection of claims in the subject patentapplication. 2023-2077 (Fed. In the initial appeal, no appointments clause argument was raised. Odyssey Logistics & Technology Corp. Stewart, Case No.
As predictions of an economic recession in the United States loom, 2023 has started with extensive layoffs throughout the tech industry. Though not to an equal degree, the biotechnology, pharmaceutical, and life science industries have not been excluded from employment cuts.
In 2023, the Patent Trial and Appeal Board (PTAB) reversed examiners’ decisions in about 30% of appeals, and only in about 7% of appeals related to patentapplications for business methods, which include financial technology (fintech) inventions.
Patent Center is slated to fully replace the legacy EFS-Web system and Private PatentApplication Information Retrieval (Private PAIR) tool on November 8, 2023. The USPTO continues to host virtual training events to help users transition to the new tool. By: WilmerHale
"This application claims priority to [properly identified earlier-filed application, the disclosure of which is expressly incorporated herein in its entirety" is a phrase commonly found in patents and patentapplications as an attempt to bolster disclosure without burdening the specification unnecessarily.
2023-2346 (Fed. affirmed the Patent Trial and Appeal Boards ruling that a published patentapplication can be deemed prior art in an IPR as of the applications filing date.Op. On January 14, 2025, the Court of Appeals for the Federal Circuit in Lynk Labs, Inc. Samsung Electronics Co., By: WilmerHale
This week, the UK supreme court finally rejected the appeal by Dr Thaler to have DABUS named as an inventor on a patentapplication. 25 sequence listing added to the pages of a divisional has now been issued ( OJ EPO 2023, A98 ). 26: Is it time for patent offices to enter the bioinformatic age? Looking beyond ST.26:
Patent and Trademark Office to reject patentapplications directed to biotechnology-related inventions, held (In re Brana) that utility of such inventions did not require demonstration of therapeutic effectiveness, those determinations being the purview of the FDA.
Patent and Trademark Office announced that the Patent Center system will fully replace the EFS-Web system and the Private PatentApplication Information Retrieval (Private PAIR) tool for the electronic filing and management of patentapplications beginning on November 8, 2023.
Legal Background: Sufficiency of disclosure for second medical use claims Under established EPO practice, the assessment of sufficiency under Article 83 EPC requires that a skilled person be able to reproduce the claimed invention using the teaching of the patentapplication as filed and common general knowledge.
March 10, 2023) In a PTAB decision that was recently designated precedential, the Board made two important decisions concerning provisional patentapplications. Critically, the Board held that the America Invents Act (AIA) brought forth a change in how provisional patentapplications are considered in the prior art analysis.
PatentApplication 15/131,442 (the “’442 Patent”) with claims directed to a method of increasing prostacyclin release in systemic blood vessels of a human to improve vasodilation and reduce hypertension. Background John L. Couvaras filed U.S.
After talking again with Jane, EL decided to patent the device. He initially filed a provisional patentapplication in June 2020. That was followed by a non-provisional patentapplication in January 2021 claiming priority back to the provisional. Question 3. What do you think?
We are pleased to announce that the Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are jointly organizing the 4th edition of their workshop on ‘Patent Opposition in the Pharmaceutical Field’ between April 24-28, 2023. The last date to apply for the workshop is March 25, 2023.
The US Patent & Trademark Office (PTO) published a notice regarding supplemental guidance for PTO personnel examining design patent claims containing computer-generated images. 80277 (Nov. By: McDermott Will & Emery
In 2014, UCB sued Actavis for infringement of the Muller patents. UCB prevailed in the lawsuit, and was awarded an injunction against Actavis until March 2021, when one of the Muller patents expires. In 2018, UCB filed a new patentapplication (the “’589 patent”, priority date 2009) covering a reformulation of Neupro.
The recent High Court decision in Ensygnia v Shell ( [2023] EWHC 1495 (Pat) ) is highly relevant to the ongoing controversy of claim interpretation and description amendments ( IPKat ). The UK approach to claim interpretation under Article 69 EPC contrasts with the EPO's approach.
On March 6, 2023, the U.S. Patent and Trademark Office (USPTO) announced the addition of a new category for its Patents for Humanity Awards Program: Green Energy. patent or patentapplication directed to green energy technologies, such as wind, solar, green hydrogen, hydropower, geothermal, and biofuel technologies.
To support the National Cancer Moonshot initiative, the USPTO launched the Cancer Moonshot Expedited Examination Pilot Program on February 1, 2023. The new program replaces the Cancer Immunotherapy Pilot Program, which expedited examination for eligible patentapplications pertaining to methods of treating cancer using immunotherapy.
On May 18, 2023, the Supreme Court of the United States issued a unanimous decision in the case of Amgen Inc. After a nine-year saga, beginning when Amgen sued Sanofi for allegedly infringing two of its patents in 2014, the Supreme Court held that Amgen’s asserted patents failed to satisfy the enablement requirement under 35 U.S.C. §
Within hours after the meeting, Berardi built his own prototype and three months later filed a patentapplication, which was granted as one of the six patents. The other five patents involve subject matter related to the first patent. Tristar counterclaimed to correct the inventorship of the six patents.
December, January, February - wake the IPKat up in March Back in December - when it was colder and darker - London's patent practitioners attended AIPPI UK’s annual patent round-up event hosted by Hogan Lovells. Over to Ada : "Before the starters, the chefs served hors d'oeuvres consisting of some outcomes from 2023.
Patent & Trademark Office (USPTO) announced that it will no longer issue patents in a printed “ribbon copy” form as of April 18, 2023. Instead, patents will now only be issued electronically in a digital form. By: Bodman
As 2023 commences, it’s time for companies to review and take stock of their intellectual property assets. Such inventions may be protectable under federal patent laws. An inventor must secure a patentapplication within a very short period of time to prevent the work from falling into the public domain.
The Federal Circuit Court of Appeals has struck down many patents on the grounds that they are invalid as directed to an abstract idea, relying on the Supreme Court’s Alice decision. 12/20/2023) 2023 U.S. Certain other categories are “patent-ineligible subject matter:” laws of nature, natural phenomena, and abstract ideas.
Patent Center Replaces EFS-Web and Private PAIR - On November 15, following a one-week delay, the legacy EFS-Web and Private PatentApplication Information Retrieval (Private PAIR) systems were officially retired and fully replaced by the Patent Center system. By: WilmerHale
Case Summaries Gilead Sciences Inc vs Union Of India on 19 December, 2024 (Madras High Court) Image from here The writ petition pertains to a patentapplication filed by the petitioner, which was contested by the 4 th respondent through a post-grant opposition. Macleods Pharmaceuticals Ltd vs The Controller Of Patents & Anr.
The Controller of Patents & Designs ( pdf ). The case involved an appeal against the order dated March 13, 2023, which had dismissed PatentApplication No. But how the court has undertaken the analysis and upheld the Controllers order for rejection of the patent is rather interesting.
Following the same mission, the Indian Patent Office has taken a drive to dispose off the patentapplications in a quicker way, provided all the procedures are properly attended by the applicant. In the way, an application was filed on 13/07/2022 for obtaining the patent protection for an Indian Applicant.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content